Carnosine: Can understanding its actions on energy metabolism and protein homeostasis inform its therapeutic potential?

Chemistry Central Journal

Volumn 7, Issue 1, 2013, Pages

  Hipkiss, Alan R ^a   Cartwright, Stephanie P ^a   Bromley, Clare ^a   Gross, Stephane R ^a   Bill, Roslyn M ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Cancer; Carnosine; Diabetes; Energy metabolism; Methylglyoxal; Parkinson's disease; Proteolysis; Reactive oxygen species (ROS); Yeast

Indexed keywords

EID: 84874187096     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-7-38     Document Type: Review

References (104)

1. McFarland GA, Holliday R. Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res 1994, 212:167-175. 10.1006/excr.1994.1132, 8187813.
2. Holliday R, McFarland GA. Inhibition of the growth of transformed and neoplastic cells by the dipeptide carnosine. Br J Cancer 1996, 73:966-971. 10.1038/bjc.1996.189, 2075811, 8611433.
3. Bauer K. Carnosine and homocarnosine, the forgotten, enigmatic peptides of the brain. Neurochem Res 2005, 30:1339-1345. 10.1007/s11064-005-8806-z, 16341596.
4. Boldyrev AA. Carnosine: new concept for the function of an old molecule. Biochemistry (Mosc) 2012, 77:313-326.
5. Dunnett M, Harris RC. High-performance liquid chromatographic determination of imidazole dipeptides, histidine, 1-methylhistidine and 3-methylhistidine in equine and camel muscle and individual muscle fibres. J Chromatogr B Biomed Sci Appl 1997, 688:47-55. 10.1016/S0378-4347(97)88054-1, 9029312.
6. Boldyrev A, Bulygina E, Leinsoo T, Petrushanko I, Tsubone S, Abe H. Protection of neuronal cells against reactive oxygen species by carnosine and related compounds. Comp Biochem Physiol B Biochem Mol Biol 2004, 137:81-88. 10.1016/j.cbpc.2003.10.008, 14698913.
7. Fontana M, Pinnen F, Lucente G, Pecci L. Prevention of peroxynitrite-dependent damage by carnosine and related sulphonamido pseudodipeptides. Cell Mol Life Sci 2002, 59:546-551. 10.1007/s00018-002-8446-2, 11964132.
8. Aldini G, Granata P, Carini M. Detoxification of cytotoxic alpha, beta-unsaturated aldehydes by carnosine: characterization of conjugated adducts by electrospray ionization tandem mass spectrometry and detection by liquid chromatography/mass spectrometry in rat skeletal muscle. J Mass Spectrom 2002, 37:1219-1228. 10.1002/jms.381, 12489081.
9. Hipkiss AR, Chana H. Carnosine protects proteins against methylglyoxal-mediated modifications. Biochem Biophys Res Commun 1998, 248:28-32. 10.1006/bbrc.1998.8806, 9675080.
10. Hipkiss AR, Michaelis J, Syrris P. Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett 1995, 371:81-85. 10.1016/0014-5793(95)00849-5, 7664889.
11. Vistoli G, Orioli M, Pedretti A, Regazzoni L, Canevotti R, Negrisoli G, Carini M, Aldini G. Design, synthesis, and evaluation of carnosine derivatives as selective and efficient sequestering agents of cytotoxic reactive carbonyl species. ChemMedChem 2009, 4:967-975. 10.1002/cmdc.200800433, 19301317.
12. Trombley PQ, Horning MS, Blakemore LJ. Interactions between carnosine and zinc and copper: implications for neuromodulation and neuroprotection. Biochemistry (Mosc) 2000, 65:807-816.
13. Abe H. Role of histidine-related compounds as intracellular proton buffering constituents in vertebrate muscle. Biochemistry (Mosc) 2000, 65:757-765.
14. Ikeda D, Wada S, Yoneda C, Abe H, Watabe S. Carnosine stimulates vimentin expression in cultured rat fibroblasts. Cell Struct Funct 1999, 24:79-87. 10.1247/csf.24.79, 10362071.
15. Kulebyakin K, Karpova L, Lakonsteva E, Krasavin M, Boldyrev A. Carnosine protects neurons against oxidative stress and modulates the time profile of MAPK cascade signaling. Amino Acids 2012, 43:91-96. 10.1007/s00726-011-1135-4, 22101981.
16. Son DO, Satsu H, Kiso Y, Totsuka M, Shimizu M. Inhibitory effect of carnosine on interleukin-8 production in intestinal epithelial cells through translational regulation. Cytokine 2008, 42:265-276. 10.1016/j.cyto.2008.02.011, 18397832.
17. Hipkiss AR. Energy metabolism, proteotoxic stress and age-related dysfunction - protection by carnosine. Mol Aspects Med 2011, 32:267-278. 10.1016/j.mam.2011.10.004, 22020113.
18. Dang CV. Links between metabolism and cancer. Genes Dev 2012, 26:877-890. 10.1101/gad.189365.112, 3347786, 22549953.
19. Granchi C, Minutolo F. Anticancer agents that counteract tumor glycolysis. ChemMedChem 2012, 7:1318-1350. 10.1002/cmdc.201200176, 22684868.
20. Warburg O. On respiratory impairment in cancer cells. Science 1956, 124:269-270.
21. Funes JM, Quintero M, Henderson S, Martinez D, Qureshi U, Westwood C, Clements MO, Bourboulia D, Pedley RB, Moncada S, Boshoff C. Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proc Natl Acad Sci U S A 2007, 104:6223-6228. 10.1073/pnas.0700690104, 1851087, 17384149.
22. Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E. Energy metabolism in tumor cells. FEBS J 2007, 274:1393-1418. 10.1111/j.1742-4658.2007.05686.x, 17302740.
23. Ertel A, Tsirigos A, Whitaker-Menezes D, Birbe RC, Pavlides S, Martinez-Outschoorn UE, Pestell RG, Howell A, Sotgia F, Lisanti MP. Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolism. Cell Cycle 2012, 11:253-263. 10.4161/cc.11.2.19006, 3293377, 22234241.
24. Natter K, Kohlwein SD. Yeast and cancer cells - common principles in lipid metabolism. Biochim Biophys Acta 2013, 1831:314-326. 10.1016/j.bbalip.2012.09.003, 3549488, 22989772.
25. Renner C, Asperger A, Seyffarth A, Meixensberger J, Gebhardt R, Gaunitz F. Carnosine inhibits ATP production in cells from malignant glioma. Neurol Res 2010, 32:101-105.
26. Renner C, Zemitzsch N, Fuchs B, Geiger KD, Hermes M, Hengstler J, Gebhardt R, Meixensberger J, Gaunitz F. Carnosine retards tumor growth in vivo in an NIH3T3-HER2/neu mouse model. Mol Cancer 2010, 9:2. 10.1186/1476-4598-9-2, 2818694, 20053283.
27. Cartwright SP, Bill RM, Hipkiss AR. L-Carnosine Affects the Growth of Saccharomyces cerevisiae in a Metabolism-Dependent Manner. PLoS One 2012, 7:e45006. 10.1371/journal.pone.0045006, 3440334, 22984600.
28. Ikeda T, Kimura K, Hama T, Tamaki N. Activation of rabbit muscle fructose 1,6-bisphosphatase by histidine and carnosine. J Biochem 1980, 87:179-185.
29. Garfinkel L, Garfinkel D. Magnesium regulation of the glycolytic pathway and the enzymes involved. Magnesium 1985, 4:60-72.
30. Wallace DC. A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found Symp 2001, 235:247-263.
31. Agathocleous M, Love NK, Randlett O, Harris JJ, Liu J, Murray AJ, Harris WA. Metabolic differentiation in the embryonic retina. Nat Cell Biol 2012, 14:859-864. 10.1038/ncb2531, 3442239, 22750943.
32. De Marchis S, Modena C, Peretto P, Migheli A, Margolis FL, Fasolo A. Carnosine-related dipeptides in neurons and glia. Biochemistry (Mosc) 2000, 65:824-833.
33. Pognetto MS, Panzanelli P, Fasolo A, Cantino D. Expression of carnosine-like immunoreactivity during retinal development in the clawed frog (Xenopus laevis). Brain Res Dev Brain Res 1992, 70:134-138. 10.1016/0165-3806(92)90111-9, 1473272.
34. Baguet A, Everaert I, Achten E, Thomis M, Derave W. The influence of sex, age and heritability on human skeletal muscle carnosine content. Amino Acids 2012, 43:13-20. 10.1007/s00726-011-1197-3, 22170500.
35. Grinio L, Stvolinsky SL. Carnosine and muscle pathologies. International Congress on Exercise and Disease; Ghent 2011, 46. 3415678, 22537216.
36. Derave W, Everaert I, Beeckman S, Baguet A. Muscle carnosine metabolism and beta-alanine supplementation in relation to exercise and training. Sports Med 2010, 40:247-263. 10.2165/11530310-000000000-00000, 20199122.
37. Nekrasova OE, Mendez MG, Chernoivanenko IS, Tyurin-Kuzmin PA, Kuczmarski ER, Gelfand VI, Goldman RD, Minin AA. Vimentin intermediate filaments modulate the motility of mitochondria. Mol Biol Cell 2011, 22:2282-2289. 10.1091/mbc.E10-09-0766, 3128530, 21562225.
38. Zakharchenko MV, Temnov AV, Kondrashova MN. Effect of carnosine on self-organization of mitochondrial assemblies in rat liver homogenate. Biochemistry (Mosc) 2003, 68:1002-1005.
39. Chondrogianni N, Gonos ES. Proteasome function determines cellular homeostasis and the rate of aging. Adv Exp Med Biol 2010, 694:38-46. 10.1007/978-1-4419-7002-2_4, 20886755.
40. Lionaki E, Markaki M, Tavernarakis N. Autophagy and ageing: Insights from invertebrate model organisms. Ageing Res Rev 2013, 12:413-428. 10.1016/j.arr.2012.05.001, 22634332.
41. Herbert AP, Riesen M, Bloxam L, Kosmidou E, Wareing BM, Johnson JR, Phelan MM, Pennington SR, Lian LY, Morgan A. NMR structure of Hsp12, a protein induced by and required for dietary restriction-induced lifespan extension in yeast. PLoS One 2012, 7:e41975. 10.1371/journal.pone.0041975, 3407059, 22848679.
42. Salway KD, Gallagher EJ, Page MM, Stuart JA. Higher levels of heat shock proteins in longer-lived mammals and birds. Mech Ageing Dev 2011, 132:287-297. 10.1016/j.mad.2011.06.002, 21703294.
43. Hipkiss AR. On the mechanisms of ageing suppression by dietary restriction-is persistent glycolysis the problem?. Mech Ageing Dev 2006, 127:8-15. 10.1016/j.mad.2005.09.006, 16274729.
44. Uchiki T, Weikel KA, Jiao W, Shang F, Caceres A, Pawlak D, Handa JT, Brownlee M, Nagaraj R, Taylor A. Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell 2012, 11:1-13. 10.1111/j.1474-9726.2011.00752.x, 3257376, 21967227.
45. Hipkiss AR. Accumulation of altered proteins and ageing: causes and effects. Exp Gerontol 2006, 41:464-473. 10.1016/j.exger.2006.03.004, 16621390.
46. Desai KM, Chang T, Wang H, Banigesh A, Dhar A, Liu J, Untereiner A, Wu L. Oxidative stress and aging: is methylglyoxal the hidden enemy?. Can J Physiol Pharmacol 2010, 88:273-284. 10.1139/Y10-001, 20393592.
47. Liu J, Wang R, Desai K, Wu L. Upregulation of aldolase B and overproduction of methylglyoxal in vascular tissues from rats with metabolic syndrome. Cardiovasc Res 2011, 92:494-503. 10.1093/cvr/cvr239, 21890532.
48. Aldini G, Orioli M, Rossoni G, Savi F, Braidotti P, Vistoli G, Yeum KJ, Negrisoli G, Carini M. The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats. J Cell Mol Med 2011, 15:1339-1354. 10.1111/j.1582-4934.2010.01101.x, 20518851.
49. Ohkawara T, Nishihira J, Nagashima R, Takeda H, Asaka M. Polaprezinc protects human colon cells from oxidative injury induced by hydrogen peroxide: relevant to cytoprotective heat shock proteins. World J Gastroenterol 2006, 12:6178-6181.
50. Mikami K, Otaka M, Watanabe D, Goto T, Endoh A, Miura K, Ohshima S, Yoneyama K, Sato M, Shibuya T. Zinc L-carnosine protects against mucosal injury in portal hypertensive gastropathy through induction of heat shock protein 72. J Gastroenterol Hepatol 2006, 21:1669-1674. 10.1111/j.1440-1746.2006.04328.x, 16984587.
51. Bonner AB, Swann ME, Marway JS, Heap LC, Preedy VR. Lysosomal and nonlysosomal protease activities of the brain in response to ethanol feeding. Alcohol 1995, 12:505-509. 10.1016/0741-8329(95)00035-6, 8590610.
52. Hipkiss AR, Brownson C, Bertani MF, Ruiz E, Ferro A. Reaction of carnosine with aged proteins: another protective process?. Ann N Y Acad Sci 2002, 959:285-294.
53. Dehvari N, Mahmud T, Persson J, Bengtsson T, Graff C, Winblad B, Ronnback A, Behbahani H. Amyloid precursor protein accumulates in aggresomes in response to proteasome inhibitor. Neurochem Int 2012, 60:533-542. 10.1016/j.neuint.2012.02.012, 22366649.
54. Pilecka I, Sadowski L, Kalaidzidis Y, Miaczynska M. Recruitment of APPL1 to ubiquitin-rich aggresomes in response to proteasomal impairment. Exp Cell Res 2011, 317:1093-1107. 10.1016/j.yexcr.2011.02.002, 3072527, 21320486.
55. Shimizu K, Kiuchi Y, Ando K, Hayakawa M, Kikugawa K. Coordination of oxidized protein hydrolase and the proteasome in the clearance of cytotoxic denatured proteins. Biochem Biophys Res Commun 2004, 324:140-146. 10.1016/j.bbrc.2004.08.231, 15464994.
56. Herrero-Mendez A, Almeida A, Fernandez E, Maestre C, Moncada S, Bolanos JP. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol 2009, 11:747-752. 10.1038/ncb1881, 19448625.
57. Rodriguez-Rodriguez P, Fernandez E, Almeida A, Bolanos JP. Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration. Cell Death Differ 2012, 19:1582-1589. 10.1038/cdd.2012.33, 3438489, 22421967.
58. Almeida A, Bolanos JP, Moncada S. E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proc Natl Acad Sci U S A 2010, 107:738-741. 10.1073/pnas.0913668107, 2818939, 20080744.
59. Hipkiss AR. Carnosine and its possible roles in nutrition and health. Adv Food Nutr Res 2009, 57:87-154.
60. Maher PA, Schubert DR. Metabolic links between diabetes and Alzheimer's disease. Expert Rev Neurother 2009, 9:617-630. 10.1586/ern.09.18, 19402773.
61. Mai A. Revelations into resveratrol's mechanism. Nat Med 2012, 18:500-501.
62. Babizhayev MA, Seguin MC, Gueyne J, Evstigneeva RP, Ageyeva EA, Zheltukhina GA. L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities. Biochem J 1994, 304(Pt 2):509-516. 1137521, 7998987.
63. Baran EJ. Metal complexes of carnosine. Biochemistry (Mosc) 2000, 65:789-797.
64. Kohen R, Yamamoto Y, Cundy KC, Ames BN. Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proc Natl Acad Sci U S A 1988, 85:3175-3179. 10.1073/pnas.85.9.3175, 280166, 3362866.
65. Chengappa KN, Turkin SR, DeSanti S, Bowie CR, Brar JS, Schlicht PJ, Murphy SL, Hetrick ML, Bilder R, Fleet D. A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia. Schizophr Res 2012, 142:145-152. 10.1016/j.schres.2012.10.001, 23099060.
66. Boldyrev AA, Gallant SC, Sukhich GT. Carnosine, the protective, anti-aging peptide. Biosci Rep 1999, 19:581-587. 10.1023/A:1020271013277, 10841274.
67. Gaunitz F, Hipkiss AR. Carnosine and cancer: a perspective. Amino Acids 2012, 43:135-142. 10.1007/s00726-012-1271-5, 22454085.
68. Scheper GC, Proud CG. Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation?. Eur J Biochem 2002, 269:5350-5359. 10.1046/j.1432-1033.2002.03291.x, 12423333.
69. Yellen P, Saqcena M, Salloum D, Feng J, Preda A, Xu L, Rodrik-Outmezguine V, Foster DA. High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1. Cell Cycle 2011, 10:3948-3956. 10.4161/cc.10.22.18124, 3266120, 22071574.
70. Villa-Cuesta E, Boylan JM, Tatar M, Gruppuso PA. Resveratrol inhibits protein translation in hepatic cells. PLoS One 2011, 6:e29513. 10.1371/journal.pone.0029513, 3248458, 22242130.
71. Logsdon CD, Fuentes MK, Huang EH, Arumugam T. RAGE and RAGE ligands in cancer. Curr Mol Med 2007, 7:777-789. 10.2174/156652407783220697, 18331236.
72. Abe R, Yamagishi S. AGE-RAGE system and carcinogenesis. Curr Pharm Des 2008, 14:940-945. 10.2174/138161208784139765, 18473843.
73. Pietkiewicz J, Bronowicka-Szydelko A, Dzierzba K, Danielewicz R, Gamian A. Glycation of the muscle-specific enolase by reactive carbonyls: effect of temperature and the protection role of carnosine, pyridoxamine and phosphatidylserine. Protein J 2011, 30:149-158. 10.1007/s10930-011-9307-3, 21347838.
74. Alhamdani MS, Al-Kassir AH, Abbas FK, Jaleel NA, Al-Taee MF. Antiglycation and antioxidant effect of carnosine against glucose degradation products in peritoneal mesothelial cells. Nephron Clin Pract 2007, 107:c26-c34. 10.1159/000106509, 17664891.
75. Alhamdani MS, Al-Azzawie HF, Abbas FK. Decreased formation of advanced glycation end-products in peritoneal fluid by carnosine and related peptides. Perit Dial Int 2007, 27:86-89.
76. Bellia F, Vecchio G, Cuzzocrea S, Calabrese V, Rizzarelli E. Neuroprotective features of carnosine in oxidative driven diseases. Mol Aspects Med 2011, 32:258-266. 10.1016/j.mam.2011.10.009, 22020110.
77. Hipkiss AR. Dietary restriction, glycolysis, hormesis and ageing. Biogerontology 2007, 8:221-224. 10.1007/s10522-006-9034-x, 16969712.
78. Hipkiss AR. Could carnosine or related structures suppress Alzheimer's disease?. J Alzheimers Dis 2007, 11:229-240.
79. Preston JE, Hipkiss AR, Himsworth DT, Romero IA, Abbott JN. Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine. Neurosci Lett 1998, 242:105-108. 10.1016/S0304-3940(98)00058-5, 9533405.
80. Fu Q, Dai H, Hu W, Fan Y, Shen Y, Zhang W, Chen Z. Carnosine protects against Abeta42-induced neurotoxicity in differentiated rat PC12 cells. Cell Mol Neurobiol 2008, 28:307-316. 10.1007/s10571-007-9235-0, 18027086.
81. Munch G, Mayer S, Michaelis J, Hipkiss AR, Riederer P, Muller R, Neumann A, Schinzel R, Cunningham AM. Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide. Biochim Biophys Acta 1997, 1360:17-29. 10.1016/S0925-4439(96)00062-2, 9061036.
82. Corona C, Frazzini V, Silvestri E, Lattanzio R, La Sorda R, Piantelli M, Canzoniero LM, Ciavardelli D, Rizzarelli E, Sensi SL. Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice. PLoS One 2011, 6:e17971. 10.1371/journal.pone.0017971, 3058055, 21423579.
83. Scozzafava A, Supuran CT. Carbonic anhydrase activators: high affinity isozymes I, II, and IV activators, incorporating a beta-alanyl-histidine scaffold. J Med Chem 2002, 45:284-291. 10.1021/jm010958k, 11784133.
84. Kida E, Palminiello S, Golabek AA, Walus M, Wierzba-Bobrowicz T, Rabe A, Albertini G, Wisniewski KE. Carbonic anhydrase II in the developing and adult human brain. J Neuropathol Exp Neurol 2006, 65:664-674. 10.1097/01.jnen.0000225905.52002.3e, 16825953.
85. Fasseas MK, Tsikou D, Flemetakis E, Katinakis P. Molecular and biochemical analysis of the alpha class carbonic anhydrases in Caenorhabditis elegans. Mol Biol Rep 2011, 38:1777-1785. 10.1007/s11033-010-0292-y, 20842438.
86. Boldyrev A, Fedorova T, Stepanova M, Dobrotvorskaya I, Kozlova E, Boldanova N, Bagyeva G, Ivanova-Smolenskaya I, Illarioshkin S. Carnosine [corrected] increases efficiency of DOPA therapy of Parkinson's disease: a pilot study. Rejuvenation Res 2008, 11:821-827. 10.1089/rej.2008.0716, 18729814.
87. Boldyrev AA, Stvolinsky SL, Fedorova TN, Suslina ZA. Carnosine as a natural antioxidant and geroprotector: from molecular mechanisms to clinical trials. Rejuvenation Res 2010, 13:156-158. 10.1089/rej.2009.0923, 20017611.
88. Licker V, Cote M, Lobrinus JA, Rodrigo N, Kovari E, Hochstrasser DF, Turck N, Sanchez JC, Burkhard PR. Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease. J Proteomics 2012, 75:4656-4667. 10.1016/j.jprot.2012.02.032, 22410244.
89. Deng Y, Zhang Y, Li Y, Xiao S, Song D, Qing H, Li Q, Rajput AH. Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains. J Neural Transm 2012, 119:435-441. 10.1007/s00702-011-0724-4, 22065205.
90. Kang JH. Salsolinol, a catechol neurotoxin, induces modification of ferritin: Protection by histidine dipeptide. Environ Toxicol Pharmacol 2010, 29:246-251. 10.1016/j.etap.2010.01.007, 21787609.
91. Hipkiss AR. Parkinson's Disease and Type-2 Diabetes: Methylglyoxal may be a Common Causal Agent; Carnosine could be Protective. Mol Med Ther 2012, 1:2.
92. Kumar PA, Kumar MS, Reddy GB. Effect of glycation on alpha-crystallin structure and chaperone-like function. Biochem J 2007, 408:251-258. 10.1042/BJ20070989, 2267351, 17696877.
93. Kim J, Sohn E, Kim CS, Kim JS. Renal podocyte apoptosis in Zucker diabetic fatty rats: involvement of methylglyoxal-induced oxidative DNA damage. J Comp Pathol 2011, 144:41-47. 10.1016/j.jcpa.2010.04.008, 20541219.
94. Negre-Salvayre A, Salvayre R, Auge N, Pamplona R, Portero-Otin M. Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal 2009, 11:3071-3109. 10.1089/ars.2009.2484, 19489690.
95. Aviles-Olmos I, Limousin P, Lees A, Foltynie T. Parkinson's disease, insulin resistance and novel agents of neuroprotection. Brain 2013, 136:374-384. 10.1093/brain/aws009, 22344583.
96. Vincent A, Briggs L, Chatwin GF, Emery E, Tomlins R, Oswald M, Middleton CA, Evans GJ, Sweeney ST, Elliott CJ. Parkin-induced defects in neurophysiology and locomotion are generated by metabolic dysfunction and not oxidative stress. Hum Mol Genet 2012, 21:1760-1769. 10.1093/hmg/ddr609, 3313793, 22215442.
97. Wahlqvist ML, Lee MS, Hsu CC, Chuang SY, Lee JT, Tsai HN. Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat Disord 2012, 18:753-758. 10.1016/j.parkreldis.2012.03.010, 22498320.
98. Rabbani N, Thornalley PJ. Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids 2012, 42:1133-1142. 10.1007/s00726-010-0783-0, 20963454.
99. Hipkiss AR. Would carnosine or a carnivorous diet help suppress aging and associated pathologies?. Ann N Y Acad Sci 2006, 1067:369-374. 10.1196/annals.1354.052, 16804013.
100. Bierhaus A, Fleming T, Stoyanov S, Leffler A, Babes A, Neacsu C, Sauer SK, Eberhardt M, Schnolzer M, Lasitschka F. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med 2012, 18:926-933. 10.1038/nm.2750, 22581285.
101. Eberhardt MJ, Filipovic MR, Leffler A, de la Roche J, Kistner K, Fischer MJ, Fleming T, Zimmermann K, Ivanovic-Burmazovic I, Nawroth PP. Methylglyoxal Activates Nociceptors through Transient Receptor Potential Channel A1 (TRPA1): a possible mechanism of metabolic neuropathies. J Biol Chem 2012, 287:28291-28306. 10.1074/jbc.M111.328674, 22740698.
102. Kamei J, Ohsawa M, Miyata S, Tanaka S. Preventive effect of L-carnosine on changes in the thermal nociceptive threshold in streptozotocin-induced diabetic mice. Eur J Pharmacol 2008, 600:83-86. 10.1016/j.ejphar.2008.10.002, 18930724.
103. Ohsawa M, Mutoh J, Asato M, Yamamoto S, Ono H, Hisa H, Kamei J. Carnosine has antinociceptive properties in the inflammation-induced nociceptive response in mice. Eur J Pharmacol 2012, 682:56-61. 10.1016/j.ejphar.2012.02.005, 22366199.
104. Everaert I, Taes Y, De Heer E, Baelde H, Zutinic A, Yard B, Sauerhofer S, Vanhee L, Delanghe J, Aldini G, Derave W. Low plasma carnosinase activity promotes carnosinemia after carnosine ingestion in humans. Am J Physiol Renal Physiol 2012, 302:F1537-F1544. 10.1152/ajprenal.00084.2012, 22496410.